A Review of Phase II Acute Heart Failure Syndromes Clinical Trials

Peter Pang, Mihai Gheorghiade

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hospitalization for acute heart failure syndromes (AHFS) is a growing health care burden. Over 1 million hospitalizations occur annually, with a postdischarge mortality and rehospitalization rate of ~45% by 90 days and a financial cost greater than $20 billion. Attempts to improve outcomes through novel therapies have largely failed, suggesting new approaches are needed. We review phase II studies in AHFS to identify opportunities for future development programs.

Original languageEnglish (US)
Pages (from-to)441-450
Number of pages10
JournalHeart Failure Clinics
Volume7
Issue number4
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Hospitalization
Heart Failure
Clinical Trials
Delivery of Health Care
Costs and Cost Analysis
Mortality
Therapeutics

Keywords

  • Acute heart failure
  • Clinical trials
  • Phase 2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

A Review of Phase II Acute Heart Failure Syndromes Clinical Trials. / Pang, Peter; Gheorghiade, Mihai.

In: Heart Failure Clinics, Vol. 7, No. 4, 10.2011, p. 441-450.

Research output: Contribution to journalArticle

Pang, Peter ; Gheorghiade, Mihai. / A Review of Phase II Acute Heart Failure Syndromes Clinical Trials. In: Heart Failure Clinics. 2011 ; Vol. 7, No. 4. pp. 441-450.
@article{109a45cb85a6466cb2114f3c4006521a,
title = "A Review of Phase II Acute Heart Failure Syndromes Clinical Trials",
abstract = "Hospitalization for acute heart failure syndromes (AHFS) is a growing health care burden. Over 1 million hospitalizations occur annually, with a postdischarge mortality and rehospitalization rate of ~45{\%} by 90 days and a financial cost greater than $20 billion. Attempts to improve outcomes through novel therapies have largely failed, suggesting new approaches are needed. We review phase II studies in AHFS to identify opportunities for future development programs.",
keywords = "Acute heart failure, Clinical trials, Phase 2",
author = "Peter Pang and Mihai Gheorghiade",
year = "2011",
month = "10",
doi = "10.1016/j.hfc.2011.06.002",
language = "English (US)",
volume = "7",
pages = "441--450",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - A Review of Phase II Acute Heart Failure Syndromes Clinical Trials

AU - Pang, Peter

AU - Gheorghiade, Mihai

PY - 2011/10

Y1 - 2011/10

N2 - Hospitalization for acute heart failure syndromes (AHFS) is a growing health care burden. Over 1 million hospitalizations occur annually, with a postdischarge mortality and rehospitalization rate of ~45% by 90 days and a financial cost greater than $20 billion. Attempts to improve outcomes through novel therapies have largely failed, suggesting new approaches are needed. We review phase II studies in AHFS to identify opportunities for future development programs.

AB - Hospitalization for acute heart failure syndromes (AHFS) is a growing health care burden. Over 1 million hospitalizations occur annually, with a postdischarge mortality and rehospitalization rate of ~45% by 90 days and a financial cost greater than $20 billion. Attempts to improve outcomes through novel therapies have largely failed, suggesting new approaches are needed. We review phase II studies in AHFS to identify opportunities for future development programs.

KW - Acute heart failure

KW - Clinical trials

KW - Phase 2

UR - http://www.scopus.com/inward/record.url?scp=80052934149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052934149&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2011.06.002

DO - 10.1016/j.hfc.2011.06.002

M3 - Article

VL - 7

SP - 441

EP - 450

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 4

ER -